Universal Ibogaine Inc. to Webcast Live at OTC Markets VirtualInvestorConferences.com March 10th Pharmaceutical Investing
Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results Life Science Investing
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
Life Sciences Virtual Investor Conference: Company Executives Present Live March 10th Pharmaceutical Investing
Phase 3 TROPiCS-02 Study Met the Primary Endpoint of Progression-Free Survival in Late-Line HR+/HER2- Metastatic Breast Cancer Pharmaceutical Investing
Merck's KEYTRUDA® Demonstrated Significant Improvement in Distant Metastasis-Free Survival Compared to Placebo as Adjuvant Therapy for Patients With Resected Stage IIB and IIC Melanoma in Phase 3 KEYNOTE-716 Trial Life Science Investing
Merck to Hold Investor Event to Highlight Growing Cardiovascular Portfolio and Pipeline Life Science Investing
U.S. Food and Drug Administration Approves Opdivo® with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer Pharmaceutical Investing
Love Pharma Updates Microdoz Proposed Acquisition with Global Leader in Psychedelic Research Pharmaceutical Investing
